TNXP Tonix Pharmaceuticals Holding Corp.

8-K Current Report

Filed: March 18, 2026

Health Care

Pharmaceutical Preparations

Tonix Pharmaceuticals Holding Corp. Overview

Tonix Pharmaceuticals Holding Corp. (TNXP) 8-K current report filed with SEC EDGAR on March 18, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 4.01: Changes in Registrant's Certifying Accountant

AI Filing Analysis
8-K

Item 4.01 · Changes in Registrant's Certifying Accountant

• New auditor PwC appointed for 2026 fiscal year and interim periods, approved by Audit Committee
• No prior consultations with PwC on accounting or audit issues in 2024, 2025, or early 2026

+2 more insights

Other Tonix Pharmaceuticals Holding Corp. 8-K Filings

8-K Mar 13, 2026

8-K Mar 10, 2026

8-K Mar 3, 2026

Get deeper insights on Tonix Pharmaceuticals Holding Corp.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.